Search
Oct 14
Ghent based Confo Therapeutics is leveraging GPCR expertise as a discovery engine - multiple partners have already signed on to the science
CEO Cedric Ververken walks us through what separates Confo from other GPCR developers, and discusses pipeline programs in pain, obesity,...